VE
Vext Science, Inc.
VEXTF · OTC
$0.18 +2.21% (+$0.00)
1M -2.70%
Market Cap $44.6M
P/E Ratio -
Div. Yield -
ROE 25.01%
Bulios Fair Price
$0.11
40.2% downside
Current Price
$0.18
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VEXTF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
85 /100
Cheap P/B 0.82x
EV/EBITDA 12.19x
P/FCF 12.86x
Growth
65 /100
Stable Book val. growth 8.40%
Rev. growth 13.86%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 18.26%
Gross margin 18.42%
FCF margin 6.88%
Quality
5 /100
Poor ROA 12.42%
ROIC 10.77%
Asset turnover 0.43x
Debt
31 /100
High Int. coverage -2.15x
Debt/Equity 0.62x
Net debt/EBITDA 4.82x
Stability
38 /100
Moderate EPS volatility 250.00%
Beta 0.80x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VEXTF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Eric J. Offenberger
Employees
173
Headquarters
Phoenix
Upcoming events
19 NOV
Earnings
Upcoming earnings report